Long-acting injectable buprenorphine cuts missed doses, boosts retention, and protects patients during high-risk transitions in the fentanyl era.
Christian Heidbreder, PhD
Advertisement
Dr Heidbreder is the chief scientific officer of Indivior Pharmaceuticals. He is also an affiliate professor at Virginia Commonwealth University School of Medicine.
Articles by Christian Heidbreder, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Neuropsychiatry in the News: Wearable Technology for Parkinson Disease, Ecopipam for Tourette Syndrome
2
Psyched Perspectives: ADHD in Underrecognized Populations, With Paige Walton, MD
3
Let’s Talk About Drug Testing
4
FDA Feedback Paves Way for New IND Filing for PT00114 in Generalized Anxiety Disorder
5